Mukka Proteins Reports Declining Sales and Profitability Challenges in June 2025 Results

Mukka Proteins, a microcap player in the FMCG sector, has reported its financial results for the quarter ending June 2025, revealing significant challenges. The company's net sales for the quarter stood at Rs 170.77 crore, reflecting a notable decline compared to the average of Rs 251.61 crore over the previous four quarters. This trend indicates a concerning trajectory for near-term sales performance.
Profit Before Tax (PBT) also showed a stark shift, recorded at Rs -0.20 crore, which contrasts sharply with the average PBT of Rs 10.93 crore from the prior four quarters. Similarly, Profit After Tax (PAT) fell to Rs 1.52 crore, a significant drop from the average of Rs 11.54 crore, highlighting a troubling trend in profitability.

Additionally, the company has experienced rising interest costs, with interest expenses reaching Rs 32.27 crore, marking a 37.44% increase over the preceding nine months. This rise suggests a reliance on increased borrowings, which could impact future financial stability. Furthermore, non-operating income constituted 108.47% of PBT, raising concerns about the sustainability of Mukka Proteins' business model.

In light of these developments, Mukka Proteins has undergone an adjustment in its evaluation, reflecting the current financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.